Preclinical investigation reveals cardiac ferritin deficiency promotes heart failure via ferroptosis, highlighting a potential therapeutic target for cardiomyopathy.
Our findings provide compelling evidence that ferritin plays a major role in protecting against cardiac ferroptosis and subsequent heart failure, thereby providing a possible new therapeutic target for patients at risk of developing cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Fang et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: